- Home
- RLMD vs LRE Comparison
RLMD vs LRE Comparison
Compare RLMD & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- LRE
- Stock Information
- Founded
- RLMD 2004
- LRE 2001
- Country
- RLMD United States
- LRE Japan
- Employees
- RLMD N/A
- LRE N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- RLMD Health Care
- LRE
- Exchange
- RLMD Nasdaq
- LRE Nasdaq
- Market Cap
- RLMD 20.3M
- LRE 24.0M
- IPO Year
- RLMD N/A
- LRE 2023
- Fundamental
- Price
- RLMD $0.59
- LRE $1.65
- Analyst Decision
- RLMD Buy
- LRE
- Analyst Count
- RLMD 3
- LRE 0
- Target Price
- RLMD $5.00
- LRE N/A
- AVG Volume (30 Days)
- RLMD 206.5K
- LRE 8.5K
- Earning Date
- RLMD 08-07-2025
- LRE 01-01-0001
- Dividend Yield
- RLMD N/A
- LRE N/A
- EPS Growth
- RLMD N/A
- LRE N/A
- EPS
- RLMD N/A
- LRE N/A
- Revenue
- RLMD N/A
- LRE $110,330,328.00
- Revenue This Year
- RLMD N/A
- LRE N/A
- Revenue Next Year
- RLMD N/A
- LRE N/A
- P/E Ratio
- RLMD N/A
- LRE N/A
- Revenue Growth
- RLMD N/A
- LRE 3.92
- 52 Week Low
- RLMD $0.24
- LRE $1.10
- 52 Week High
- RLMD $3.98
- LRE $2.49
- Technical
- Relative Strength Index (RSI)
- RLMD 44.70
- LRE 41.55
- Support Level
- RLMD $0.60
- LRE $1.61
- Resistance Level
- RLMD $0.67
- LRE $1.85
- Average True Range (ATR)
- RLMD 0.06
- LRE 0.09
- MACD
- RLMD -0.00
- LRE -0.03
- Stochastic Oscillator
- RLMD 16.42
- LRE 7.41
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.